PTEN and neoplasm: If human PTEN mutant SHH-MB have a similar differentiated cellular phenotype to mouse models, then targeting such tumors with drugs to kill proliferating cells will not remove the bulk of the tumor and will require the drugs having access to the rare proliferating GCP-like tumor stem-like cells.